Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.

Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.

The Liver Imaging Reporting and Data System (LI-RADS) is widely adopted for the noninvasive diagnosis of hepatocellular carcinoma (HCC). Herein, possible strategies to improve the diagnostic performance of LR-5 without reducing specificity for HCC were investigated. This retrospective study included...

Full description

Bibliographic Details
Main Authors:	Jae Hyon Park, Yong Eun Chung, Nieun Seo, Jin-Young Choi, Mi-Suk Park, Myeong-Jin Kim
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0242344

Similar Items

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
by: Yeun-Yoon Kim, et al.
Published: (2019-09-01)

Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement.
by: Honsoul Kim, et al.
Published: (2014-01-01)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
by: Jens Ricke, et al.
Published: (2020-12-01)

Value of Image Subtraction for the Identification of Hepatocellular Carcinoma Capsule on Gadoxetic Acid-Enhanced MRI
by: Hyunjung Kim, et al.
Published: (2018-12-01)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
by: Viktoria Palm, et al.
Published: (2018-03-01)

A Comprehensive Review of Hepatocellular Carcinoma Enhancement Patterns in MRI: Emphasis on Gadoxetate-Enhanced Imaging
by: Seung-seob Kim, et al.
Published: (2019-05-01)

Intraluminal Duodenal Diverticulum: CT and Gadoxetic Acid-Enhanced MRI Findings
by: Jeong Myeong Kim, et al.
Published: (2015-03-01)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
by: Kyoung Doo Song, et al.
Published: (2015-06-01)

A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma
by: Yi Wei, et al.
Published: (2020-04-01)

A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions
by: Chansik An, et al.
Published: (2017-03-01)

Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study
by: Meng Zhou, et al.
Published: (2021-03-01)

Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
by: Chenyi Rao, et al.
Published: (2020-04-01)

Hepatocellular carcinoma composed of two different histologic types: imaging features on gadoxetic acid-enhanced liver MRI
by: Seung Hyun Kim, et al.
Published: (2013-03-01)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
by: Morikatsu Yoshida, MD, et al.
Published: (2020-08-01)

Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI
by: Yun-Jin Jang, et al.
Published: (2013-11-01)

An excerpt of 2016 consensus recommendations of the Korean Society of Abdominal Radiology about diagnosis of hepatocellular carcinoma with Gadoxetic Acid-enhanced MRI
by: HAN Bing, et al.
Published: (2017-07-01)

Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).
by: Jae Seok Bae, et al.
Published: (2017-01-01)

Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis.
by: Dahye Lee, et al.
Published: (2015-01-01)

Feasibility of radiation dose reduction with iterative reconstruction in abdominopelvic CT for patients with inappropriate arm positioning.
by: Nieun Seo, et al.
Published: (2018-01-01)

Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
by: Mustafa Kurucay, et al.
Published: (2017-06-01)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
by: Sarah E. Lochrin, et al.
Published: (2021-03-01)

Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
by: Jimi Huh, et al.
Published: (2019-11-01)

A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma
by: Mario A. Cedillo, MD, et al.
Published: (2020-02-01)

Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
by: Chong H, et al.
Published: (2021-06-01)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
by: Fang, Z., et al.
Published: (2022)

Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.
by: Xijiao Liu, et al.
Published: (2013-01-01)

Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction
by: Zhen Zhang, et al.
Published: (2019-05-01)

Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
by: Ingo G. Steffen, et al.
Published: (2021-12-01)

Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients.
by: John N Morelli, et al.
Published: (2013-01-01)

A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI
by: Aboelyazid Elkilany, et al.
Published: (2021-05-01)

¹⁸F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary study.
by: Sung Jun Ahn, et al.
Published: (2013-01-01)

Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI
by: Lukas Haider, et al.
Published: (2018-01-01)

Metal implants influence CT scan parameters leading to increased local radiation exposure: A proposal for correction techniques.
by: Ok Kyu Song, et al.
Published: (2019-01-01)

Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
by: Vincenza Granata, et al.
Published: (2019-07-01)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
by: So Yeon Kim
Published: (2020-07-01)

Detection of Hypervascular Hepatocellular Carcinoma: Comparison between Gadoxetic Acid-enhanced Magnetic Resonance Imaging and Diffusion Weighted Image
by: Suwannee Surattanasophon
Published: (2014-07-01)

Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols.
by: Kristina I Ringe, et al.
Published: (2018-01-01)

Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy
by: Chengguang Hu, et al.
Published: (2021-05-01)

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma
by: Daniel Puhr-Westerheide, et al.
Published: (2019-11-01)

Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
by: Xiang Li, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_0j9mq4v7r3ceqtk2v2me6hk4fu